Capital Management Associates Bristol Myers Squibb CO Transaction History

Capital Management Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $206,945 - $241,939	-3,775 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $175,160 - $254,548	3,775 New	3,775 $210,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $177,974 - $230,789	-3,650 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$50.53 - $62.98 $184,434 - $229,877	3,650 New	3,650 $202,000
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $218,708 - $251,777	-3,650 Closed	0 $0
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $35,964 - $39,210	-600 Reduced 14.12%	3,650 $224,000
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $234,727 - $270,895	4,250	4,250 $271,000

2,402

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $112B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Capital Management Associates , based on Form 13F filings with the SEC.

Stay updated on Capital Management Associates with notifications on news.